Skip to main content
Erschienen in: Immunologic Research 5/2020

18.08.2020 | Original Article

TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation

verfasst von: Lorraine Vieira Alves, Suellen Rodrigues Martins, Ana Cristina Simões e Silva, Carolina Neris Cardoso, Karina Braga Gomes, Ana Paula Lucas Mota

Erschienen in: Immunologic Research | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Cytokine polymorphisms can influence their plasma levels and thus affect the immune response in renal transplantation. A total of 146 renal transplant recipients (RTR) were classified into groups according to the estimated glomerular filtration rate (R1: < 60 and R2: ≥ 60 mL/min/1.73 m2) and time after transplantation (T1: 1 to 24, T2: 25 to 60, T3: 61 to 120, and T4: > 120 months after transplantation). The polymorphisms were genotyped by single specific primer-polymerase chain reaction. IL-10 was measured by ELISA and IL-6, and TNF levels were determined using Miliplex®. A higher frequency of the − 308G allele and the − 308G/G genotype, low-producer, was observed in the R1 group compared with R2. In addition, a higher frequency of the − 308A carriers, high-producer, was found in the R2 group. However, no significant difference was observed in cytokine levels when both groups were compared. Higher levels of IL-6 were observed in T1 compared with T2 and T4 groups. Lower IL-6 levels were found in T2 compared with T3 group. Lower levels of IL-10 were also found in T1 group in relation to T2, while higher levels of this cytokine were observed in T2 group compared with T3. The results suggest that the − 308G > A polymorphism in the TNF gene is associated with filtration function after renal transplantation, and IL-6 and IL-10 levels change according to the time after transplantation. Thus, the joint evaluation of − 308G > A polymorphism in TNF gene and IL-6 and IL-10 levels would provide a broader and effective view on the clinical monitoring of RTR.
Literatur
1.
Zurück zum Zitat Jarl J, Desatnik P, Hansson UP, Prütz KG, Gerdtham U. Do kidney transplantations save money? A study using a before-after design and multiple register-based data from Sweden. Clin Kidney J. 2018;11:283–8.PubMed Jarl J, Desatnik P, Hansson UP, Prütz KG, Gerdtham U. Do kidney transplantations save money? A study using a before-after design and multiple register-based data from Sweden. Clin Kidney J. 2018;11:283–8.PubMed
2.
Zurück zum Zitat Ponticelli C. The mechanisms of acute transplant rejection revisited. J Nephrol. 2012;25:150–8.PubMed Ponticelli C. The mechanisms of acute transplant rejection revisited. J Nephrol. 2012;25:150–8.PubMed
3.
Zurück zum Zitat Gu L, Tao Y, Chen C, Ye Y, Xiong X, Sun Y. Initiation of the inflammatory response after renal ischemia/reperfusion injury during renal transplantation. Int Urol Nephrol. 2018;50:2027–35.PubMed Gu L, Tao Y, Chen C, Ye Y, Xiong X, Sun Y. Initiation of the inflammatory response after renal ischemia/reperfusion injury during renal transplantation. Int Urol Nephrol. 2018;50:2027–35.PubMed
4.
Zurück zum Zitat Srinivas L, Vellichirammal NN, Alex AM, Nair C, Nair IV, Banerjee M. Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. J Neuroinflammation. 2016;13:105.PubMedPubMedCentral Srinivas L, Vellichirammal NN, Alex AM, Nair C, Nair IV, Banerjee M. Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. J Neuroinflammation. 2016;13:105.PubMedPubMedCentral
5.
Zurück zum Zitat Schmid H, Lederer SR. Urinary biomarkers: on the long road to personalized renal transplant medicine. Pol Arch Intern Med. 2019;129:577–9.PubMed Schmid H, Lederer SR. Urinary biomarkers: on the long road to personalized renal transplant medicine. Pol Arch Intern Med. 2019;129:577–9.PubMed
6.
Zurück zum Zitat Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87:281–96.PubMed Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87:281–96.PubMed
7.
Zurück zum Zitat Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736–46.PubMed Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736–46.PubMed
8.
Zurück zum Zitat Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Rümmele P, et al. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant. 2009;9:675–86.PubMed Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Rümmele P, et al. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant. 2009;9:675–86.PubMed
9.
Zurück zum Zitat Sánchez-fructuoso AI, Pérez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, et al. The polymorphism −308G/A of tumor necrosis factor-α gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection. J Immunol Res. 2016;2016:2197595.PubMedPubMedCentral Sánchez-fructuoso AI, Pérez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, et al. The polymorphism −308G/A of tumor necrosis factor-α gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection. J Immunol Res. 2016;2016:2197595.PubMedPubMedCentral
10.
Zurück zum Zitat Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-g: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:721–812. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-g: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:721–812.
11.
Zurück zum Zitat Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40:40–50.PubMedPubMedCentral Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40:40–50.PubMedPubMedCentral
12.
Zurück zum Zitat Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534–41.PubMed Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534–41.PubMed
13.
Zurück zum Zitat Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL- 6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:369–76. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL- 6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:369–76.
14.
Zurück zum Zitat Jia W, Fei GH, Hu JG, Hu XW. A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer. Onco Targets Ther. 2015;8:2699–704.PubMedPubMedCentral Jia W, Fei GH, Hu JG, Hu XW. A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer. Onco Targets Ther. 2015;8:2699–704.PubMedPubMedCentral
15.
Zurück zum Zitat Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.PubMed Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.PubMed
16.
Zurück zum Zitat Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant. 2013;3:91–8.PubMedPubMedCentral Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant. 2013;3:91–8.PubMedPubMedCentral
17.
Zurück zum Zitat Liu F, Li B, Wang WT, Wei YG, Yan LN, Wen TF, et al. Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis. World J Gastroenterol. 2012;18:847–54.PubMedPubMedCentral Liu F, Li B, Wang WT, Wei YG, Yan LN, Wen TF, et al. Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis. World J Gastroenterol. 2012;18:847–54.PubMedPubMedCentral
18.
Zurück zum Zitat Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.PubMed Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.PubMed
19.
Zurück zum Zitat Amirzargar A, Lessanpezeshki M, Fathi A, Amirzargar M, Khosravi F, Ansaripour B, et al. Th1/Th2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc. 2005;37:2985–7.PubMed Amirzargar A, Lessanpezeshki M, Fathi A, Amirzargar M, Khosravi F, Ansaripour B, et al. Th1/Th2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc. 2005;37:2985–7.PubMed
20.
Zurück zum Zitat Elnokeety MM, Shaker AM, Fayed AM. Urinary interleukin-10 in renal transplant recipients: does it predict a state of tolerance or rejection. Saudi J Kidney Dis Transpl. 2017;28:1196–200.PubMed Elnokeety MM, Shaker AM, Fayed AM. Urinary interleukin-10 in renal transplant recipients: does it predict a state of tolerance or rejection. Saudi J Kidney Dis Transpl. 2017;28:1196–200.PubMed
21.
Zurück zum Zitat Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Yaghobi R, Rais-Jalali GA, et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol Biol Rep. 2012;39:509–15.PubMed Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Yaghobi R, Rais-Jalali GA, et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol Biol Rep. 2012;39:509–15.PubMed
22.
23.
Zurück zum Zitat Cucchiari D. Podestà Ma, Ponticelli C. the critical role of innate immunity in kidney transplantation. Nephron. 2016;132:227–37.PubMed Cucchiari D. Podestà Ma, Ponticelli C. the critical role of innate immunity in kidney transplantation. Nephron. 2016;132:227–37.PubMed
24.
Zurück zum Zitat Levin A, Stevens PE, Bilous RW, Coresh J, Francisco ALM, Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150. Levin A, Stevens PE, Bilous RW, Coresh J, Francisco ALM, Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
25.
Zurück zum Zitat Miller WG, Jones GRD. Estimated glomerular filtration rate; laboratory implementation and current global status. Adv Chronic Kidney Dis. 2018;25:7–13.PubMed Miller WG, Jones GRD. Estimated glomerular filtration rate; laboratory implementation and current global status. Adv Chronic Kidney Dis. 2018;25:7–13.PubMed
26.
Zurück zum Zitat Rodrigues FB, Bruetto RG, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria. PLoS One. 2013;8:e69998.PubMedPubMedCentral Rodrigues FB, Bruetto RG, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria. PLoS One. 2013;8:e69998.PubMedPubMedCentral
27.
Zurück zum Zitat Halloran PF, Langone AJ, Helderman JH, Kaplan B. Assessing long-term nephron loss: is it time to kick the CAN grading system? Am J Transplant. 2004;4:1729–30.PubMed Halloran PF, Langone AJ, Helderman JH, Kaplan B. Assessing long-term nephron loss: is it time to kick the CAN grading system? Am J Transplant. 2004;4:1729–30.PubMed
28.
Zurück zum Zitat Samaan F, Requião-Moura LR, Pinheiro HS, Ozaki KS, Câmara NOS, Pacheco-Silva A. Prevalence and progression of chronic kidney disease after renal transplantation. Transplant Proc. 2011;43:2587–91.PubMed Samaan F, Requião-Moura LR, Pinheiro HS, Ozaki KS, Câmara NOS, Pacheco-Silva A. Prevalence and progression of chronic kidney disease after renal transplantation. Transplant Proc. 2011;43:2587–91.PubMed
29.
Zurück zum Zitat Naderi GH, Mehraban D, Kazemeyni SM, Darvishi M, Latif AH. Living or deceased donor kidney transplantation: a comparison of results and survival rates among Iranian patients. Transplant Proc. 2009;41:2772–4.PubMed Naderi GH, Mehraban D, Kazemeyni SM, Darvishi M, Latif AH. Living or deceased donor kidney transplantation: a comparison of results and survival rates among Iranian patients. Transplant Proc. 2009;41:2772–4.PubMed
30.
Zurück zum Zitat Nemati E, Einollahi B, Lesan Pezeshki M, Porfarziani V, Fattahi MR. Does kidney transplantation with deceased or living donor affect graft survival? Nephrourol Mon. 2014;6:e12182.PubMedPubMedCentral Nemati E, Einollahi B, Lesan Pezeshki M, Porfarziani V, Fattahi MR. Does kidney transplantation with deceased or living donor affect graft survival? Nephrourol Mon. 2014;6:e12182.PubMedPubMedCentral
31.
Zurück zum Zitat Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation. 1994;57:1450–4.PubMed Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation. 1994;57:1450–4.PubMed
32.
Zurück zum Zitat Hu Q, Tian H, Wu Q, Li J, Cheng X, Liao P. Interleukin-10-1082 G/a polymorphism and acute renal graft rejection: a meta-analysis. Ren Fail. 2016;38:57–64.PubMed Hu Q, Tian H, Wu Q, Li J, Cheng X, Liao P. Interleukin-10-1082 G/a polymorphism and acute renal graft rejection: a meta-analysis. Ren Fail. 2016;38:57–64.PubMed
33.
Zurück zum Zitat Perovic V, Markovic M, Kravljaca M, Milosevic E, Djoric M, Pravica V, et al. Cytokine gene polymorphism profiles in kidney transplant patients - association of +1188A/C RS3212227 SNP in the IL12B gene prevents delayed graft function. Arch Med Res. 2018;49:101–8.PubMed Perovic V, Markovic M, Kravljaca M, Milosevic E, Djoric M, Pravica V, et al. Cytokine gene polymorphism profiles in kidney transplant patients - association of +1188A/C RS3212227 SNP in the IL12B gene prevents delayed graft function. Arch Med Res. 2018;49:101–8.PubMed
34.
Zurück zum Zitat Rashad RH, Mahmoud KM, Hady TMAA, El-Agroudy AEB, Hamdy AF, Ismail AM, et al. IL-10 gene polymorphism and graft outcome in live- donor kidney transplantation. J Egypt Soc Nephrol Transplant. 2016, 2016;16:89–96. Rashad RH, Mahmoud KM, Hady TMAA, El-Agroudy AEB, Hamdy AF, Ismail AM, et al. IL-10 gene polymorphism and graft outcome in live- donor kidney transplantation. J Egypt Soc Nephrol Transplant. 2016, 2016;16:89–96.
35.
Zurück zum Zitat Xiong J, Wang Y, Zhang Y, Nie L, Wang D, Huang Y, et al. Lack of association between interleukin-10 gene polymorphisms and graft rejection risk in kidney transplantation recipients: a meta-analysis. PLoS One. 2015;10:e0127540.PubMedPubMedCentral Xiong J, Wang Y, Zhang Y, Nie L, Wang D, Huang Y, et al. Lack of association between interleukin-10 gene polymorphisms and graft rejection risk in kidney transplantation recipients: a meta-analysis. PLoS One. 2015;10:e0127540.PubMedPubMedCentral
36.
Zurück zum Zitat Khan F, Sar A, Gonul I, Benediktsson H, Doulla J, Yilmaz S, et al. Graft inflammation and histologic indicators of kidney chronic allograft failure: low-expressing interleukin-10 genotypes cannot be ignored. Transplantation. 2010;90:630–8.PubMed Khan F, Sar A, Gonul I, Benediktsson H, Doulla J, Yilmaz S, et al. Graft inflammation and histologic indicators of kidney chronic allograft failure: low-expressing interleukin-10 genotypes cannot be ignored. Transplantation. 2010;90:630–8.PubMed
37.
Zurück zum Zitat Thakkinstian A, Dmitrienko S, Gerbase-Delima M, McDaniel DO, Inigo P, Chowet KM, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant. 2008;23:3017–23.PubMed Thakkinstian A, Dmitrienko S, Gerbase-Delima M, McDaniel DO, Inigo P, Chowet KM, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant. 2008;23:3017–23.PubMed
38.
Zurück zum Zitat La Manna G, Cappuccilli ML, Capelli I, Baraldi O, Cuna V, Battaglino G, et al. The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. Ann Transplant. 2013;18:256–64.PubMed La Manna G, Cappuccilli ML, Capelli I, Baraldi O, Cuna V, Battaglino G, et al. The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. Ann Transplant. 2013;18:256–64.PubMed
39.
Zurück zum Zitat Kocierz M, Siekiera U, Kolonko A, Karkoszka H, Chudek J, Cierpka L, et al. 174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period. Tissue Antigens. 2011;77:283–90.PubMed Kocierz M, Siekiera U, Kolonko A, Karkoszka H, Chudek J, Cierpka L, et al. 174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period. Tissue Antigens. 2011;77:283–90.PubMed
40.
Zurück zum Zitat Arbab M, Tahir S, Niazi MK, Ishaq M, Hussain A, Siddique PM, et al. TNF-α genetic predisposition and higher expression of inflammatory pathway components in keratoconus. Invest Ophthalmol Vis Sci. 2017;58:3481–7.PubMed Arbab M, Tahir S, Niazi MK, Ishaq M, Hussain A, Siddique PM, et al. TNF-α genetic predisposition and higher expression of inflammatory pathway components in keratoconus. Invest Ophthalmol Vis Sci. 2017;58:3481–7.PubMed
41.
Zurück zum Zitat Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha −308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol. 2006;16:194–9.PubMed Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha −308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol. 2006;16:194–9.PubMed
42.
Zurück zum Zitat Dhaouadi T, Sfar I, Bardi R, Jendoubi-Ayed S, Abdallah TB, Ayed K, et al. Cytokine gene polymorphisms in kidney transplantation. Transplant Proc. 2013;45:2152–7.PubMed Dhaouadi T, Sfar I, Bardi R, Jendoubi-Ayed S, Abdallah TB, Ayed K, et al. Cytokine gene polymorphisms in kidney transplantation. Transplant Proc. 2013;45:2152–7.PubMed
43.
Zurück zum Zitat Masli S, Turpie B. Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells. Immunology. 2009;127:62–72.PubMedPubMedCentral Masli S, Turpie B. Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells. Immunology. 2009;127:62–72.PubMedPubMedCentral
44.
Zurück zum Zitat Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13:135–41. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13:135–41.
45.
Zurück zum Zitat Agnoli C, Grioni S, Pala V, Allione A, Matullo G, Gaetano CD, et al. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort. Sci Rep. 2017;7:12708.PubMedPubMedCentral Agnoli C, Grioni S, Pala V, Allione A, Matullo G, Gaetano CD, et al. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort. Sci Rep. 2017;7:12708.PubMedPubMedCentral
46.
Zurück zum Zitat Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, et al. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J Immunol. 2010;185:1412–8.PubMed Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, et al. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J Immunol. 2010;185:1412–8.PubMed
47.
Zurück zum Zitat Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Tumor necrosis factor α and regulatory T cells in Oncoimmunology. Front Immunol. 2018;9:444.PubMedPubMedCentral Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Tumor necrosis factor α and regulatory T cells in Oncoimmunology. Front Immunol. 2018;9:444.PubMedPubMedCentral
48.
Zurück zum Zitat Pierini A, Strober W, Moffett C, Baker J, Nishikii H, Alvarez M, et al. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Blood. 2016;128:866–71.PubMedPubMedCentral Pierini A, Strober W, Moffett C, Baker J, Nishikii H, Alvarez M, et al. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Blood. 2016;128:866–71.PubMedPubMedCentral
49.
Zurück zum Zitat Bazzaz JT, Amoli MM, Taheri Z, Larijani B, Pravica V, Hutchinson IV. TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications. J Diabetes Metab Disord. 2014;13:46.PubMedPubMedCentral Bazzaz JT, Amoli MM, Taheri Z, Larijani B, Pravica V, Hutchinson IV. TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications. J Diabetes Metab Disord. 2014;13:46.PubMedPubMedCentral
50.
Zurück zum Zitat Beyer M, Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, et al. Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection. Nat Immunol. 2016;17:593–603.PubMed Beyer M, Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, et al. Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection. Nat Immunol. 2016;17:593–603.PubMed
51.
Zurück zum Zitat Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci U S A. 2008;105:13644–9.PubMedPubMedCentral Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci U S A. 2008;105:13644–9.PubMedPubMedCentral
52.
Zurück zum Zitat Kotowski M, Bogacz A, Bartkowiak-wieczorek J, Sienko J, Procyk D, Dziewanowski K, et al. The influence of the tumor necrosis factor-alpa-308G>A polymorphism on the efficacy of immunosuppressive therapy in patients after kidney transplantation. J Physiol Pharmacol. 2016;67:819–26. Kotowski M, Bogacz A, Bartkowiak-wieczorek J, Sienko J, Procyk D, Dziewanowski K, et al. The influence of the tumor necrosis factor-alpa-308G>A polymorphism on the efficacy of immunosuppressive therapy in patients after kidney transplantation. J Physiol Pharmacol. 2016;67:819–26.
53.
Zurück zum Zitat Mota APL, Menezes CA, Alpoim PN, Cardoso CN, Martins SR, Alves LV, et al. Regulatory and pro-inflammatory cytokines in brazilian living-related renal transplant recipients according to creatinine plasma levels. Nephrology (Carlton). 2017;23:867–75. Mota APL, Menezes CA, Alpoim PN, Cardoso CN, Martins SR, Alves LV, et al. Regulatory and pro-inflammatory cytokines in brazilian living-related renal transplant recipients according to creatinine plasma levels. Nephrology (Carlton). 2017;23:867–75.
54.
Zurück zum Zitat Alves LV, Maia MJO, Nunes FFC, Magalhães HPB, Afonso DAF, Mota APL. Creatinine and cytokines plasma levels related to HLA compatibility in kidney transplant patients. J Bras Patol Med Lab. 2015;51:303–9. Alves LV, Maia MJO, Nunes FFC, Magalhães HPB, Afonso DAF, Mota APL. Creatinine and cytokines plasma levels related to HLA compatibility in kidney transplant patients. J Bras Patol Med Lab. 2015;51:303–9.
55.
Zurück zum Zitat Newell KA. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010;120:1836–47.PubMedPubMedCentral Newell KA. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010;120:1836–47.PubMedPubMedCentral
56.
Zurück zum Zitat Nova-Lamperti E, Fanelli G, Becker PD, Chana P, Elgueta R, Dodd PC, et al. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses. Sci Rep. 2016;6:20044.PubMedPubMedCentral Nova-Lamperti E, Fanelli G, Becker PD, Chana P, Elgueta R, Dodd PC, et al. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses. Sci Rep. 2016;6:20044.PubMedPubMedCentral
57.
Zurück zum Zitat Ma L, Zhang H, Hu K, Lv G, Fu Y, Ayana DA, Zhao P, Jiang Y Desalegn Admassu Ayana. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. BMC Immunol 2015;16:56. Ma L, Zhang H, Hu K, Lv G, Fu Y, Ayana DA, Zhao P, Jiang Y Desalegn Admassu Ayana. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. BMC Immunol 2015;16:56.
58.
Zurück zum Zitat Edemir B, Kurian SM, Eisenacher M, Lang D, Müller-Tidow C, Gabriëls G, et al. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics. 2008;9:71.PubMedPubMedCentral Edemir B, Kurian SM, Eisenacher M, Lang D, Müller-Tidow C, Gabriëls G, et al. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics. 2008;9:71.PubMedPubMedCentral
59.
Zurück zum Zitat Mazanowska O, Kamińska D, Krajewska M, Banasik M, Zabińska M, Kościelska-Kasprzak K, et al. Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation. Transplant Proc. 2013;45:1458–61.PubMed Mazanowska O, Kamińska D, Krajewska M, Banasik M, Zabińska M, Kościelska-Kasprzak K, et al. Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation. Transplant Proc. 2013;45:1458–61.PubMed
60.
Zurück zum Zitat Reinhold SW, Straub RH, Krüger B, Kaess B, Bergler T, Weingart C, et al. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Cytokine. 2012;57(3):379–88.PubMed Reinhold SW, Straub RH, Krüger B, Kaess B, Bergler T, Weingart C, et al. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Cytokine. 2012;57(3):379–88.PubMed
61.
Zurück zum Zitat Jin Z, Xu C, Duan W, Yang J, Tian P. The level of IL-2 and IL-6 in stimulated peripheral lymphocyte supernatants of kidney transplant recipients can predict acute renal allograft rejection. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:1024–9.PubMed Jin Z, Xu C, Duan W, Yang J, Tian P. The level of IL-2 and IL-6 in stimulated peripheral lymphocyte supernatants of kidney transplant recipients can predict acute renal allograft rejection. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:1024–9.PubMed
62.
Zurück zum Zitat Chen X, Oppenheim JJ. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett. 2011;585:3611–8.PubMedPubMedCentral Chen X, Oppenheim JJ. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett. 2011;585:3611–8.PubMedPubMedCentral
63.
Zurück zum Zitat Budak D, Yilmaz VT, Akbas H, Suleymanlar G, Yucel G. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation. Ren Fail. 2015;37:871–6.PubMed Budak D, Yilmaz VT, Akbas H, Suleymanlar G, Yucel G. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation. Ren Fail. 2015;37:871–6.PubMed
64.
Zurück zum Zitat Lima JR, Salgado JV, Ferreira TC, Oliveira MI, Santos AM, Salgado Filho N. Cystatin C and inflammatory markers in kidney transplant recipients. Rev Assoc Med Bras (1992). 2011;57:347–52. Lima JR, Salgado JV, Ferreira TC, Oliveira MI, Santos AM, Salgado Filho N. Cystatin C and inflammatory markers in kidney transplant recipients. Rev Assoc Med Bras (1992). 2011;57:347–52.
65.
Zurück zum Zitat Jung YJ, Lee HR, Kwon OJ. Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants. J Korean Surg Soc. 2012;83:69–74.PubMedPubMedCentral Jung YJ, Lee HR, Kwon OJ. Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants. J Korean Surg Soc. 2012;83:69–74.PubMedPubMedCentral
66.
Zurück zum Zitat Matsunami M, Ubara Y, Sumida K, Oshima Y, Oguro M, Kinoshita K, et al. The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. BMC Nephrol. 2018;19:263.PubMedPubMedCentral Matsunami M, Ubara Y, Sumida K, Oshima Y, Oguro M, Kinoshita K, et al. The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. BMC Nephrol. 2018;19:263.PubMedPubMedCentral
67.
Zurück zum Zitat Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005;79:914–9.PubMed Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005;79:914–9.PubMed
68.
Zurück zum Zitat Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, et al. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei. Sci Rep. 2017;7:42791.PubMedPubMedCentral Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, et al. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei. Sci Rep. 2017;7:42791.PubMedPubMedCentral
69.
Zurück zum Zitat Boucault L, Bézie S, Ossart J, Guillonneau C. Tolerance in organ transplantation. In: Abdeldayem H, El-Kased AF, El-Shaarawy A, editors. Frontiers in Transplantology. 1rd ed. IntechOpen: Croatia; 2016. p. 47–87. Boucault L, Bézie S, Ossart J, Guillonneau C. Tolerance in organ transplantation. In: Abdeldayem H, El-Kased AF, El-Shaarawy A, editors. Frontiers in Transplantology. 1rd ed. IntechOpen: Croatia; 2016. p. 47–87.
70.
Zurück zum Zitat Cooper JE, Wiseman AC. Novel immunosuppressive agents in kidney transplantation. Clin Nephrol. 2010;73:333–43.PubMed Cooper JE, Wiseman AC. Novel immunosuppressive agents in kidney transplantation. Clin Nephrol. 2010;73:333–43.PubMed
71.
Zurück zum Zitat Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol. 2009;39:2331–6.PubMed Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol. 2009;39:2331–6.PubMed
72.
Zurück zum Zitat Mota AP, Vilaça SS, das Mercês FL Jr, Pinheiro Mde B, Teixeira-Carvalho A, Silveira AC, et al. Cytokines signatures in short and long-term stable renal transplanted patients. Cytokine. 2013;62:302–9.PubMed Mota AP, Vilaça SS, das Mercês FL Jr, Pinheiro Mde B, Teixeira-Carvalho A, Silveira AC, et al. Cytokines signatures in short and long-term stable renal transplanted patients. Cytokine. 2013;62:302–9.PubMed
Metadaten
Titel
TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation
verfasst von
Lorraine Vieira Alves
Suellen Rodrigues Martins
Ana Cristina Simões e Silva
Carolina Neris Cardoso
Karina Braga Gomes
Ana Paula Lucas Mota
Publikationsdatum
18.08.2020
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 5/2020
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-020-09147-3

Weitere Artikel der Ausgabe 5/2020

Immunologic Research 5/2020 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.